Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol

Lancet Respir Med. 2019 Aug;7(8):655-656. doi: 10.1016/S2213-2600(19)30136-5. Epub 2019 May 7.

Authors

Affiliations

¹ International Agency for Research on Cancer, Lyon, France. Electronic address: robbinsh@iarc.fr.
² Leeds Teaching Hospitals, Leeds, UK.
³ Kings College London, London, UK.
⁴ University College London, London, UK.
⁵ National Cancer Institute, Rockville, MD, USA.
⁶ International Agency for Research on Cancer, Lyon, France.
⁷ University of Nottingham, Nottingham, UK.

No abstract available

Publication types

Review

MeSH terms

Early Detection of Cancer / methods*
Humans
Lung Neoplasms / diagnostic imaging*
Mass Screening / methods*
Tomography, X-Ray Computed / methods*
United Kingdom

Grants and funding